|
163
|
475
|
9ms2A |
Crystal structure of human cyp3a5 in complex with sjyhj-111 |
|
129
|
414
|
9cwiA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(5-((3,3-difluoroazetidin-1-yl)methyl)-2,3-difluorophenyl)-4-methylpyridin-2-amine dihydrochloride |
|
123
|
414
|
9cw7A |
Structure of human endothelial nitric oxide synthase heme domain bound with 4-methyl-5'-((methylamino)methyl)-[2,3'-bipyridin]-6-amine dihydrochloride |
|
125
|
414
|
9cw4A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(3-fluoro-5-((methylamino)methyl)phenyl)-4-methylpyridin-2-amine dihydrochloride |
|
125
|
419
|
9cvnA |
Structure of rat neuronal nitric oxide synthase bound with 6-(2,3-difluoro-5-((methylamino)methyl)phenyl)-4-methylpyridin-2-amine dihydrochloride |
|
127
|
414
|
9cw8A |
Structure of human endothelial nitric oxide synthase heme domain bound with 3-(6-amino-4-methylpyridin-2-yl)-5-((methylamino)methyl)benzonitrile dihydrochloride |
|
134
|
419
|
9cw3A |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain bound with 6-(5-((4,4-difluoropiperidin-1-yl)methyl)-2,3-difluorophenyl)-4-methylpyridin-2-amine dihydrochloride |
|
123
|
469
|
9ms1A |
Crystal structure of human cyp3a4 in complex with sjyhj-111 |
|
124
|
414
|
9cw5A |
Structure of human endothelial nitric oxide synthase heme domain bound with 4-methyl-6-(3-((methylamino)methyl)-5-(trifluoromethyl)phenyl)pyridin-2-amine dihydrochloride |
|
122
|
414
|
9cw2A |
Structure of human endothelial nitric oxide synthase heme domain bound with 4-methyl-6-(3-((methylamino)methyl)phenyl)pyridin-2-amine dihydrochloride |
|
128
|
414
|
9cwdA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(5-((dimethylamino)methyl)-2,3-difluorophenyl)-4-methylpyridin-2-amine dihydrochloride |
|
133
|
414
|
9cwkA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(2,3-difluoro-5-(2-(methylamino)ethyl)phenyl)-4-methylpyridin-2-amine dihydrochloride |
|
127
|
414
|
9cwjA |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(5-((4,4-difluoropiperidin-1-yl)methyl)-2,3-difluorophenyl)-4-methylpyridin-2-amine dihydrochloride |
|
123
|
414
|
9cw6A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(3-chloro-5-((dimethylamino)methyl)phenyl)-4-methylpyridin-2-amine dihydrochloride |
|
126
|
414
|
9cw9A |
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(2,3-difluoro-5-((methylamino)methyl)phenyl)-4-methylpyridin-2-amine dihydrochloride |
|
472
|
1218
|
9e5wA |
Proline utilization a (puta) from sinorhizobium meliloti inactivated by n-propargylglycine |
|
132
|
468
|
9couA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
129
|
468
|
9cosA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
123
|
374
|
9dizA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm959 (6-cyclopropyl-2,4-dimethyl-3-((6-(trifluoromethyl)pyridin-3-yl)methyl)-2,6-dihydro-7h-pyrazolo[3,4-c]pyridin-7-one) |
|
137
|
468
|
9cotA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
154
|
469
|
9coyA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
139
|
469
|
9covA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
137
|
374
|
9di6A |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm679 (ethyl 1,4-dimethyl-5-((6-(trifluoromethyl)pyridin-3-yl)methyl)-1h-pyrazole-3-carboxylate) |
|
130
|
470
|
9coxA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
123
|
469
|
9cowA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
145
|
378
|
9dikA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm681 (n-cyclopropyl-1,4-dimethyl-5-((6-(trifluoromethyl)pyridin-3-yl)methyl)-1h-pyrazole-3-carboxamide) |
|
153
|
469
|
9corA |
Crystal structure of cyp3a4 bound to an inhibitor |
|
44
|
163
|
8ta0A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor mam881 |
|
45
|
163
|
8tbrA |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor mam758 |
|
46
|
163
|
8ta1A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor mam907 |
|
144
|
413
|
8t7nA |
Crystal structure of the r132h mutant of idh1 bound to compound 1 |
|
142
|
414
|
8t7oA |
Crystal structure of the r132h mutant of idh1 bound to ag-120 |
|
145
|
353
|
9at2A |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with pan3 inhibitor |
|
147
|
352
|
9b1qA |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with pyn1 inhibitor |
|
142
|
352
|
8w1hA |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with pyn3 inhibitor |
|
147
|
353
|
8vugA |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with ppn1 inhibitor |
|
146
|
352
|
8w2kA |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with pan3f inhibitor |
|
141
|
353
|
9b17A |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with pan1 inhibitor |
|
150
|
352
|
8vtqA |
Crystal structure of human tryptophan 2,3-dioxygenase in complex with ppn3 inhibitor |
|
225
|
666
|
8frqA |
Lsd1-corest in complex with t14, long soaking |
|
228
|
666
|
8frvA |
Lsd1-corest in complex with t17, short soaking |
|
215
|
666
|
8fskA |
Lsd1-corest in complex with t18, short soaking |
|
42
|
133
|
8frvB |
Lsd1-corest in complex with t17, short soaking |
|
220
|
666
|
8friA |
Lsd1-corest in complex with aw4, short soaking |
|
41
|
133
|
8friB |
Lsd1-corest in complex with aw4, short soaking |
|
41
|
133
|
8frqB |
Lsd1-corest in complex with t14, long soaking |
|
41
|
133
|
8fskB |
Lsd1-corest in complex with t18, short soaking |
|
102
|
327
|
9bk3A |
Crystal structure of lactate dehydrogenase in complex with 4-((4-(1-methyl-1h-imidazole-2-carbonyl)phenyl)amino)-4-oxo-2-(4-(trifluoromethyl)phenyl)butanoic acid (r-enantiomer, orthorhombic p form) |
|
123
|
331
|
9bk2A |
Crystal structure of lactate dehydrogenase in complex with 4-((4-(1-methyl-1h-imidazole-2-carbonyl)phenyl)amino)-4-oxo-2-(4-(trifluoromethyl)phenyl)butanoic acid (s-enantiomer, monoclinic p form) |
|
133
|
468
|
9bbbA |
Human cyp3a4 bound to an inhibitor |